BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6789633)

  • 1. Intralesional BCG injection of pulmonary neoplasms: radiographic findings.
    Fon GT; Bein ME; Holmes EC; Huberman RP
    AJR Am J Roentgenol; 1981 Aug; 137(2):269-75. PubMed ID: 6789633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma.
    Millar JW; Hunter AM; Wightman AJ; Horne NW
    Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG immunotherapy of lung cancer.
    Holmes EC
    Jpn J Surg; 1980 Mar; 10(1):1-6. PubMed ID: 7373947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional BCG immunotherapy of pulmonary tumors.
    Holmes EC; Ramming KP; Bein ME; Coulson WF; Callery CD
    J Thorac Cardiovasc Surg; 1979 Mar; 77(3):362-8. PubMed ID: 762979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE; Crispen RG; Nika B
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic tuberculosis, mycobacteriosis, MERosis, and BCGosis in a cancer treatment center.
    Hill CA
    Radiology; 1984 Nov; 153(2):311-6. PubMed ID: 6484160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional immunotherapy with intrapleural BCG for lung cancer.
    McKneally MF; Maver C; Kausel HW; Alley RD
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):333-8. PubMed ID: 785107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma.
    Millar JW; Roscoe P; Pearce SJ; Ludgate S; Horne NW
    Thorax; 1982 Jan; 37(1):57-60. PubMed ID: 7041323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase I study.
    Cusumano CL; Jernigan JA; Waldman RH
    J Natl Cancer Inst; 1975 Aug; 55(2):275-9. PubMed ID: 169370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulation with intrapleural BCG as adjuvant therapy in resected non-small cell lung cancer. The Ludwig Lung Cancer Study Group (LLCSG).
    Cancer; 1986 Dec; 58(11):2411-6. PubMed ID: 2876770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):649-57. PubMed ID: 7029149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery, BCG immunotherapy, and multichemotherapy in T3 stage-3 bronchogenic carcinoma.
    Rioseco A
    Chest; 1981 Feb; 79(2):176-85. PubMed ID: 7460649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
    Mastrangelo MJ; Bellet RE; Berkelhammer J; Clark WH
    Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
    Bjornsson S; Takita H; Kuberka N; Preisler H; Catane H; Higby D; Henderson E
    Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors.
    Lamm DL; Harris SC; Gittes RF
    Invest Urol; 1977 Mar; 14(5):369-72. PubMed ID: 844999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.